Darren A.E. Cross

Also affiliated with AstraZeneca (Poland)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Efficacy of osimertinib against EGFRvIII+ glioblastoma”.

Efficacy of osimertinib against EGFRvIII+ glioblastoma

Oncotarget(2020)10.18632/oncotarget.27599

N/A

0DataRank · unranked

57 citations

Shawn G. Kwatra, Cory Nanni, Callie Roberts, S. Phillips, Sarah Nullmeyergh +13 more

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

Cancer Research(2020)10.1158/0008-5472.can-19-3819

N/A

0DataRank · unranked

60 citations

Alexis Guernet, Maria Emanuela Cuomo, Kamrine E. Poels, Iris K. van Alderwerelt van Rosenburgh, Amy Nagelberg +19 more